What are the effects of prednisone on bone marrow function and blood cell counts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Prednisone Effects on Bone Marrow

Prednisone does not directly suppress bone marrow function in the traditional sense of causing cytopenias; rather, it causes a rapid redistribution of white blood cells, increases peripheral neutrophil counts through demargination, and can stimulate erythropoiesis in certain contexts, while the primary bone marrow concern when using prednisone is monitoring for azathioprine-induced bone marrow depression when these drugs are used together.

Direct Hematologic Effects of Prednisone

White Blood Cell Changes

Prednisone causes immediate and predictable changes in peripheral white blood cell counts within hours of administration 1. The differential white blood cell count changes significantly:

  • Neutrophilia occurs rapidly due to demargination of neutrophils from vessel walls and release from bone marrow reserves 2
  • Lymphopenia develops as lymphocytes redistribute from peripheral blood to lymphoid tissues 3
  • These changes are dose-dependent and reversible, occurring at doses as low as 10 mg daily 1

Important clinical pitfall: The neutrophilia induced by prednisone is not true bone marrow stimulation but rather redistribution. Do not interpret elevated white counts during steroid therapy as infection unless other clinical signs are present.

Effects on Erythropoiesis

Prednisone can stimulate erythropoiesis in normal bone marrow 4. In a study of children with immune thrombocytopenic purpura receiving prednisone, there was a significant increase in hemoglobin and red blood cell counts during treatment, demonstrating that corticosteroids enhance red blood cell production in vivo when bone marrow is functioning normally 4.

In specific cases of prednisone-responsive aplastic anemia, corticosteroids work by inhibiting cortisol-sensitive T lymphocytes that suppress granulopoiesis 5. However, this is an immunologic mechanism rather than direct bone marrow stimulation.

Platelet Effects

Prednisone does not directly affect platelet production but is used therapeutically in immune thrombocytopenia (ITP) at doses of 1 mg/kg/day (range 0.5-2 mg/kg/day) 3. The mechanism is immunosuppression of platelet destruction, not bone marrow stimulation.

Bone Marrow Monitoring Requirements

When Prednisone is Used with Azathioprine

The critical bone marrow concern arises when prednisone is combined with azathioprine, as recommended in autoimmune hepatitis treatment 6:

Monitor blood counts regularly when using combination therapy:

  • Azathioprine should be promptly reduced or stopped if significant bone marrow depression occurs 6
  • Complications of azathioprine include bone marrow suppression, cholestatic hepatitis, pancreatitis, nausea, and rash 7
  • Side effects develop in fewer than 10% of patients receiving 50 mg daily of azathioprine 7

TPMT Testing Before Azathioprine

Measure thiopurine methyltransferase (TPMT) enzyme activity before starting azathioprine to exclude homozygosity for TPMT deficiency 6:

  • Low enzyme activity occurs in only 0.3% of the population 7
  • Heterozygotes with intermediate activity constitute 11% of the population 7
  • Pretreatment testing is a reasonable clinical precaution, especially in patients with preexisting cytopenia 7

Prednisone Monotherapy and Bone Marrow

Prednisone alone does not cause bone marrow suppression 8. The FDA label for prednisone does not list bone marrow suppression as an adverse effect when used as monotherapy 8.

Documented Adverse Effects (Not Bone Marrow Related)

The primary concerns with prednisone monotherapy include 8:

  • Hematologic: Anemia and neutropenia (including febrile neutropenia) are listed but are rare
  • Metabolic: Negative nitrogen balance, hyperglycemia
  • Musculoskeletal: Osteoporosis, vertebral compression fractures
  • Endocrine: HPA axis suppression, cushingoid features
  • Cardiovascular: Hypertension, fluid retention

Clinical Monitoring Algorithm

For Prednisone Monotherapy

  • No routine bone marrow monitoring required
  • Monitor for expected WBC redistribution (neutrophilia, lymphopenia)
  • Address osteoporosis risk with calcium, vitamin D, and bisphosphonates in high-risk patients 6

For Prednisone + Azathioprine Combination

Implement systematic blood count monitoring 6:

  1. Check CBC with differential at baseline
  2. Monitor regularly during treatment (frequency based on clinical context)
  3. Reduce or stop azathioprine promptly if significant cytopenias develop
  4. Consider TPMT testing before initiating azathioprine, particularly in patients with baseline cytopenia

Special Populations

Patients with cirrhosis have higher frequency of drug-related complications (25% vs 8%) and cytopenia that may compromise azathioprine tolerance 9. These patients require closer monitoring.

Key Distinction

The question of "prednisone effect on bone marrow" must distinguish between:

  1. Direct prednisone effects: Redistribution of WBCs, potential stimulation of erythropoiesis, no bone marrow suppression
  2. Indirect concerns: Monitoring for azathioprine-induced bone marrow depression when drugs are combined
  3. Immunologic effects: Suppression of immune-mediated bone marrow suppression in specific conditions like prednisone-responsive aplastic anemia

Prednisone itself is not a bone marrow suppressant and does not require bone marrow monitoring when used alone. The monitoring imperative arises from concurrent immunosuppressive agents, particularly azathioprine.

References

2
Research

Effect of prednisolone on the growth of human bone marrow cells in vitro.

British journal of experimental pathology, 1978

4
Research

The influence of corticosteroids on human erythropoiesis. An in vivo study.

The American journal of pediatric hematology/oncology, 1988

Related Questions

Should I use prednisone or an alternative medication for my condition?
What are the hematologic effects of prednisone and how should they be monitored and managed?
When will prednisone begin to reduce inflammation and relieve symptoms?
At what daily dose and duration of prednisone (or equivalent) should a steroid taper be initiated?
Can I flush out prednisone with water?
What are the next treatment options for a patient with AST 181 U/L, ALT 132 U/L, and a BUN/creatinine ratio of 8?
Does a 66-year-old man with documented primary hypogonadism and a normal prostate-specific antigen require a follow‑up with a urologist?
In a 3-year-old who had a tonsillectomy and adenoidectomy a year ago and now presents with four days of fever, nasal congestion, cough, fever responding to acetaminophen, and no lethargy, can he still have a Group A streptococcal infection?
What is the appropriate management for burning and tingling pain on the medial ankle and heel after increasing exercise?
What is the appropriate management for a 36-year-old woman with new marked leukocytosis (WBC 22.1 ×10⁹/L, absolute neutrophil count 17.0 ×10⁹/L), thrombocytosis (platelets 572 ×10⁹/L), mild hypokalemia (potassium 3.4 mmol/L), low bicarbonate (CO₂ 19 mmol/L), elevated alkaline phosphatase (159 U/L), dyslipidemia (LDL 143 mg/dL, HDL 39 mg/dL, total cholesterol 204 mg/dL), vitamin D insufficiency (24.4 ng/mL), and well‑controlled type 2 diabetes (A1c 5.3 %)?
Can a mastectomy result in chest wall neuropathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.